|
- In a November 7 announcement, the NHMRC indicates that the Universal Funding Rules have been updated to note the potential problems of cell line contamination and recommend "that researchers employ quality assurance procedures to ensure their eukaryotic cell lines are free from mycoplasma and other contaminant cells, and are verified as the cell type required".
- "Curing Cell Lines" by Jeffrey M. Perkel, BioTechniques 51:85-90 (2011) [full text], discusses the forthcoming international standards for cell line identification, including comment from Dr Amanda Capes-Davis, founding manager of CellBank Australia.
- In an associated editorial, the BioTechniques Editor-in-Chief, Nathan S. Blow, announces BioTechniques will require the validation of all cell lines used in manuscripts from January 2012.
|
|
Conferences and presentations
- Dr Amanda Capes-Davis will present a seminar entitled "Good Cell Culture Practice: Insights from CellBank Australia" at the Children's Cancer Institute Australia on August 18, 2011 at 4 pm.
- CellBank Australia will chair the "Clever cell culture for the innovation of biologics" session at AusBiotech2011 on Thursday, October 18, 2011. Speakers include:
|
|
|
Publications
- Version 6.7 of the List of Cross-Contaminated or Misidentified Cell Lines (June 27, 2011) by Amanda Capes-Davis and R. Ian Freshney is now available
- "Check your cultures! A list of cross-contaminated or misidentified cell lines", Capes-Davis A, Theodosopoulos G, Atkin I, Drexler, HG, Kohara A, MacLeod RAF, Masters JR, Nakamura Y, Reid YA, Reddel RR, and Freshney RI, Int. J. Cancer 127:1-8 (2010) [full text].
|
|
|